ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0024

An International Delphi Consensus on Non-pharmacological Interventions for Fibromyalgia

Burak Kundakci1, Michelle Hall1, Fabiola Atzeni2, Jaime C. Branco3, Dan Buskila4, Daniel Clauw5, Leslie J. Crofford6, Mary-Ann Fitzcharles7, Vasileios Georgopoulos8, Robert D. Gerwin9, Eva Kosek10, Gary Macfarlane11, Caroline Neal12, Nathan J. Rudin13, Sarah Ryan14, José A. P. da Silva15, Ann Taylor16, Dennis C. Turk17, Daniel Whibley18, Michael Doherty19, Weiya Zhang20 and Abhishek Abhishek1, 1University of Nottingham, Nottingham, United Kingdom, 2Rheumatology Unit, University of Messina, Messina, Italy, 33.CEDOC, NOVA Medical School, Faculdade de Ciências Médicas da Universidade NOVA de Lisboa, Lisboa, Portugal; 7.Hospital Egas Moniz (CHLO) (Rheumatology Department), Lisboa, Portugal, Lisboa, Portugal, 4Ben Gurion University of the Negev, Beer – Sheva, Israel, Beer-Sheva, Israel, 5Michigan Medicine, Ann Arbor, MI, 6Vanderbilt University Medical Center, Nashville, TN, 7McGill University, montreal, Canada, 8University of Nottingham, Nottingham, 9Johns Hopkins University, Baltimore, 10Karolinska Institutet, Stockholm, Sweden, 11University of Aberdeen, Aberdeen, Scotland, United Kingdom, 12Primary Integrated Community Services Ltd, Nottingham, United Kingdom, 13University of Wisconsin, Madison, 14Midlands NHS Foundation Trust and Keele University, Stoke on trent, United Kingdom, 159.Centro Hospitalar e Universitário Coimbra (Rheumatology Department), Coimbra, Portugal, Coimbra, Portugal, 16Cardiff University School of Medicine, Cardiff, United Kingdom, 17University of Washington School of Medicine, Seattle, WA, 18University of Aberdeen, Ann Arbor, MI, 19Academic Rheumatology, School of Medicine, University of Nottingham, UK, Nottingham, England, United Kingdom, 20Academic Rheumatology, School of Medicine, University of Nottingham, UK, Nottingham, United Kingdom

Meeting: ACR Convergence 2020

Keywords: fibromyalgia, Rehabilitation

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Friday, November 6, 2020

Title: Fibromyalgia & Other Clinical Pain Syndromes Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Fibromyalgia (FM) impacts directly on health and quality of life (QoL) of patients and associates with a large health economic burden. Non-pharmacological interventions are recommended as first-line treatment for FM1. However, there are no evidence-based recommendation for which intervention(s) to offer to patients with different manifestations of FM as core and adjunctive treatments. The aim of this Delphi exercise was to prioritise non-pharmacological treatments for FM based on the results of our meta-analysis2.

Methods: A three-stage Delphi exercise was designed. Panel members were selected from the author list of EULAR, American Pain Society and Canadian FM guidelines and local clinicians with expertise in FM. In the first round Delphi survey, participants were asked to select interventions that they thought should be offered to people with FM, and then rate these interventions as either core or adjunctive treatments separately for pain, fatigue, sleep and depression. They were provided a summary of current research evidence from our recent meta-analysis to support their decision-making. Items receiving more than 70% votes were accepted, those receiving less than 30% were rejected and those obtaining between 30-70% were recirculated in the following rounds.

Results: Seventeen of 48 invitees agreed to participate and completed the 3 rounds of the survey. There were 7 rheumatologists, 2 physiotherapists, 1 pain specialist,1 psychologist, 1 nurse and 5 other professionals. This Delphi exercise identified 14 non-pharmacological interventions for pain, 11 for fatigue, 12 for sleep and 11 for depression that were considered potentially accessible and beneficial for the four common manifestations of FM (Table 1). Aerobic exercise, education, sleep hygiene and cognitive behavioural therapy were supported as core treatments for all manifestations. Other interventions, including music, periods of relaxation/enjoyment during the day, use of hot baths and local heat, achieved consensus as adjunctive treatments for certain outcomes (Table 2).

Conclusion: This Delphi exercise provides an up-to-date consensus of expert practitioners and researchers on core and adjunctive non-pharmacological treatments for four manifestations of FM, specifically pain, fatigue, sleep and depression. This information will inform the development of a complex non-pharmacological treatment package for FM which will subsequently be tested in clinical research.

  1. Macfarlane, G.J., et al., EULAR revised recommendations for the management of fibromyalgia. Annals of the rheumatic diseases, 2017. 76(2): p. 318-328.
  2. Kundakci B, Kaur J, Goh S, Hall M, Doherty M, Zhang W, Abhishek A. The Efficacy of Non-Pharmacological Interventions for Fibromyalgia: A Systematic Review with Meta-Analysis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/the-efficacy-of-non-pharmacological-interventions-for-fibromyalgia-a-systematic-review-with-meta-analysis/. Accessed May 27, 2020.

Table 1. Accepted non-pharmacological interventions and percentage of agreement for pain, fatigue, sleep and depression

Table 2. The classification of accepted non-pharmacological interventions as core or adjunctive for pain, fatigue, sleep and depression


Disclosure: B. Kundakci, None; M. Hall, None; F. Atzeni, None; J. Branco, None; D. Buskila, None; D. Clauw, Pfizer, 1, 2, Tonix, 1, Aptinyx, 1, 2, Daiichi Sankyo, 1, Samumed, 1, Intec Pharma, 1, Eli Lilly, 1, Zynerba, 1, Williams & Connolly LLP, 1, Nix Patterson LLP, 1, Theravance, 1; L. Crofford, None; M. Fitzcharles, None; V. Georgopoulos, None; R. Gerwin, None; E. Kosek, None; G. Macfarlane, Amgen, 1, GlaxoSmithKline, 1; C. Neal, None; N. Rudin, None; S. Ryan, None; J. da Silva, MyFibromyalgia®, a webcompany delivering services to patients with Fibromyalgia, 9; A. Taylor, None; D. Turk, None; D. Whibley, None; M. Doherty, None; W. Zhang, None; A. Abhishek, None.

To cite this abstract in AMA style:

Kundakci B, Hall M, Atzeni F, Branco J, Buskila D, Clauw D, Crofford L, Fitzcharles M, Georgopoulos V, Gerwin R, Kosek E, Macfarlane G, Neal C, Rudin N, Ryan S, da Silva J, Taylor A, Turk D, Whibley D, Doherty M, Zhang W, Abhishek A. An International Delphi Consensus on Non-pharmacological Interventions for Fibromyalgia [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/an-international-delphi-consensus-on-non-pharmacological-interventions-for-fibromyalgia/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/an-international-delphi-consensus-on-non-pharmacological-interventions-for-fibromyalgia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology